Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood

Human Molecular Genetics

Volumn 21, Issue 2, 2012, Pages 371-383

  Toperoff, Gidon ^a   Aran, Dvir ^a,b   Kark, Jeremy D ^b   Rosenberg, Michael ^a   Dubnikov, Tatyana ^a   Nissan, Batel ^a   Wainstein, Julio ^c   Friedlander, Yechiel ^b   Levy Lahad, Ephrat ^a   Glaser, Benjamin ^d   Hellman, Asaf ^a  

^a HEBREW UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c WOLFSON MEDICAL CENTER   (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; BINDING SITE; BLOOD; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; ENHANCER REGION; FEMALE; GENE; GENE LOCATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC VARIABILITY; GENOME; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; SEX DIFFERENCE; TRANSCRIPTION REGULATION;

ADULT; AGED; CASE-CONTROL STUDIES; CPG ISLANDS; DIABETES MELLITUS, TYPE 2; DNA METHYLATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED;

EID: 84855400734     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr472     Document Type: Article

References (45)

1. Prokopenko, I., McCarthy, M.I. and Lindgren, C.M. (2008) Type 2 diabetes: new genes, new understanding. Trends Genet., 24, 613-621.
2. Voight, B.F., Scott, L.J., Steinthorsdottir, V., Morris, A.P., Dina, C., Welch, R.P., Zeggini, E., Huth, C., Aulchenko, Y.S., Thorleifsson, G. et al. (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet., 42, 579-589.
3. Bjornsson, H.T., Fallin, M.D. and Feinberg, A.P. (2004) An integrated epigenetic and genetic approach to common human disease. Trends Genet., 20, 350-358.
4. Portela, A. and Esteller, M. (2010) Epigenetic modifications and human disease. Nat. Biotechnol., 28, 1057-1068.
5. Petronis, A. (2010) Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature, 465, 721-727.
6. Hellman, A. and Chess, A. (2007) Gene body-specific methylation on the active X chromosome. Science, 315, 1141-1143.
7. Ball, M.P., Li, J.B., Gao, Y., Lee, J.H., LeProust, E.M., Park, I.H., Xie, B., Daley, G.Q. and Church, G.M. (2009) Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat. Biotechnol., 27, 361-368.
8. Lister, R., Pelizzola, M., Dowen, R.H., Hawkins, R.D., Hon, G., Tonti-Filippini, J., Nery, J.R., Lee, L., Ye, Z., Ngo, Q.M. et al. (2009) Human DNA methylomes at base resolution show widespread epigenomic differences. Nature, 462, 315-322.
9. Rakyan, V.K., Down, T.A., Balding, D.J. and Beck, S. (2011) Epigenome-wide association studies for common human diseases. Nat. Rev. Genet., 12, 529-541.
10. Docherty, S.J., Davis, O.S., Haworth, C.M., Plomin, R. and Mill, J. (2009) Bisulfite-based epityping on pooled genomic DNA provides an accurate estimate of average group DNA methylation. Epigenet. Chromatin, 2:3.
11. Docherty, S.J., Davis, O.S., Haworth, C.M., Plomin, R. and Mill, J. (2010) DNA methylation profiling using bisulfite-based epityping of pooled genomic DNA. Methods, 52, 255-258.
12. Aran, D., Toperoff, G., Rosenberg, M. and Hellman, A. (2011) Replication timing-related and gene body-specific methylation of active human genes. Hum. Mol. Genet., 20, 670-680.
13. Frayling, T.M., Timpson, N.J., Weedon, M.N., Zeggini, E., Freathy, R.M., Lindgren, C.M., Perry, J.R., Elliott, K.S., Lango, H., Rayner, N.W. et al. (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science, 316, 889-894.
14. Kerkel, K., Spadola, A., Yuan, E., Kosek, J., Jiang, L., Hod, E., Li, K., Murty, V.V., Schupf, N., Vilain, E. et al. (2008) Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation. Nat. Genet., 40, 904-908.
15. Hellman, A. and Chess, A. (2010) Extensive sequence-influenced DNA methylation polymorphism in the human genome. Epigenet. Chromatin., 3, 11.
16. Schalkwyk, L.C., Meaburn, E.L., Smith, R., Dempster, E.L., Jeffries, A.R., Davies, M.N., Plomin, R. and Mill, J. (2010) Allelic skewing of DNA methylation is widespread across the genome. Am. J. Hum. Genet., 86, 196-212.
17. Frazer, K.A., Ballinger, D.G., Cox, D.R., Hinds, D.A., Stuve, L.L., Gibbs, R.A., Belmont, J.W., Boudreau, A., Hardenbol, P., Leal, S.M. et al. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature, 449, 851-861.
18. Bell, C.G., Finer, S., Lindgren, C.M., Wilson, G.A., Rakyan, V.K., Teschendorff, A.E., Akan, P., Stupka, E., Down, T.A., Prokopenko, I. et al. (2010) Integrated genetic and epigenetic analysis identifies haplotype-specific methylation in the FTO type 2 diabetes and obesity susceptibility locus. PLoS One, 5, e14040.
19. Lango, H., Palmer, C.N., Morris, A.D., Zeggini, E., Hattersley, A.T., McCarthy, M.I., Frayling, T.M. and Weedon, M.N. (2008) Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes, 57, 3129-3135.
20. Herder, C., Rathmann, W., Strassburger, K., Finner, H., Grallert, H., Huth, C., Meisinger, C., Gieger, C., Martin, S., Giani, G. et al. (2008) Variants of the PPARG, IGF2BP2, CDKAL1, HHEX, and TCF7L2 genes confer risk of type 2 diabetes independently of BMI in the German KORA studies. Horm. Metab. Res., 40, 722.
21. Bressler, J., Kao, W.H., Pankow, J.S. and Boerwinkle, E. (2010) Risk of type 2 diabetes and obesity is differentially associated with variation in FTO in whites and African-Americans in the ARIC study. PLoS One, 5, E10521.
22. Hertel, J.K., Johansson, S., Sonestedt, E., Jonsson, A., Lie, R.T., Platou, C.G., Nilsson, P.M., Rukh, G., Midthjell, K., Hveem, K. et al. (2011) FTO, Type 2 diabetes, and weight gain throughout adult life: a meta-analysis of 41 504 subjects from the Scandinavian HUNT, MDC, and MPP studies. Diabetes, 60, 1637-1644.
23. Kark, J.D., Sinnreich, R., Leitersdorf, E., Friedlander, Y., Shpitzen, S. and Luc, G. (2000) Taq1B CETP polymorphism, plasma CETP, lipoproteins, apolipoproteins and sex differences in a Jewish population sample characterized by low HDL-cholesterol. Atherosclerosis, 151, 509-518.
24. Wingender, E., Dietze, P., Karas, H. and Knuppel, R. (1996) TRANSFAC: a database on transcription factors and their DNA binding sites. Nucleic Acids Res., 24, 238-241.
25. Johnson, D.S., Mortazavi, A., Myers, R.M. and Wold, B. (2007) Genome-wide mapping of in vivo protein-DNA interactions. Science, 316, 1497-1502.
26. Vallet, V.S., Casado, M., Henrion, A.A., Bucchini, D., Raymondjean, M., Kahn, A. and Vaulont, S. (1998) Differential roles of upstream stimulatory factors 1 and 2 in the transcriptional response of liver genes to glucose. J. Biol. Chem., 273, 20175-20179.
27. van Deursen, D., Jansen, H. and Verhoeven, A.J. (2008) Glucose increases hepatic lipase expression in HepG2 liver cells through upregulation of upstream stimulatory factors 1 and 2. Diabetologia, 51, 2078-2087.
28. Wong, R.H., Chang, I., Hudak, C.S., Hyun, S., Kwan, H.Y. and Sul, H.S. (2009) A role of DNA-PK for the metabolic gene regulation in response to insulin. Cell, 136, 1056-1072.
29. Watt, F. and Molloy, P.L. (1988) Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. Genes Dev., 2, 1136-1143.
30. Prendergast, G.C. and Ziff, E.B. (1991) Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science, 251, 186-189.
31. Campanero, M.R., Armstrong, M.I. and Flemington, E.K. (2000) CpG methylation as a mechanism for the regulation of E2F activity. Proc. Natl Acad. Sci. USA, 97, 6481-6486.
32. Nyblom, H.K., Bugliani, M., Fung, E., Boggi, U., Zubarev, R., Marchetti, P. and Bergsten, P. (2009) Apoptotic, regenerative, and immune-related signaling in human islets from type 2 diabetes individuals. J. Proteome Res., 8, 5650-5656.
33. Kong, A., Steinthorsdottir, V., Masson, G., Thorleifsson, G., Sulem, P., Besenbacher, S., Jonasdottir, A., Sigurdsson, A., Kristinsson, K.T., Frigge, M.L. et al. (2009) Parental origin of sequence variants associated with complex diseases. Nature, 462, 868-874.
34. Cedar, H. and Bergman, Y. (2009) Linking DNA methylation and histone modification: patterns and paradigms. Nat. Rev. Genet., 10, 295-304.
35. Xu, J., Pope, S.D., Jazirehi, A.R., Attema, J.L., Papathanasiou, P., Watts, J.A., Zaret, K.S., Weissman, I.L. and Smale, S.T. (2007) Pioneer factor interactions and unmethylated CpG dinucleotides mark silent tissue-specific enhancers in embryonic stem cells. Proc. Natl Acad. Sci. USA, 104, 12377-12382.
36. Xu, C.R., Cole, P.A., Meyers, D.J., Kormish, J., Dent, S. and Zaret, K.S. (2011) Chromatin "prepattern" and histone modifiers in a fate choice for liver and pancreas. Science, 332, 963-966.
37. Sérandour, A.A., Avner, S., Percevault, F., Demay, F., Bizot, M., Lucchetti-Miganeh, C., Barloy-Hubler, F., Brown, M., Lupien, M., Metivier, R. et al. (2011) Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers. Genome Res., 21, 555-565.
38. Li, Z., Schug, J., Tuteja, G., White, P. and Kaestner, K.H. (2011) The nucleosome map of the mammalian liver. Nat. Struct. Mol. Biol., 18, 742-746.
39. Friedlander, Y., Manor, O., Paltiel, O., Meiner, V., Sharon, N., Calderon, R., Hochner, H., Sagy, Y., Avgil, M., Harlap, S. et al. (2009) Birth weight of offspring, maternal pre-pregnancy characteristics, and mortality of mothers: the Jerusalem perinatal study cohort. Ann. Epidemiol., 19, 112-117.
40. Durbin, R.M., Abecasis, G.R., Altshuler, D.L., Auton, A., Brooks, L.D., Gibbs, R.A., Hurles, M.E. and McVean, G.A. (2010) A map of human genome variation from population-scale sequencing. Nature, 467, 1061-1073.
41. Rohde, C., Zhang, Y., Reinhardt, R. and Jeltsch, A. (2010) BISMA-fast and accurate bisulfite sequencing data analysis of individual clones from unique and repetitive sequences. BMC Bioinform., 11, 230.
42. Kark, J.D., Sinnreich, R., Rosenberg, I.H., Jacques, P.F. and Selhub, J. (2002) Plasma homocysteine and parental myocardial infarction in young adults in Jerusalem. Circulation, 105, 2725-2729.
43. Mikkelsen, T.S., Ku, M., Jaffe, D.B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., Brockman, W., Kim, T.K., Koche, R.P. et al. (2007) Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature, 448, 553-560.
44. Benjamini, Y. and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B Met., 57, 289-300.
45. Storey, J.D. and Tibshirani, R. (2003) Statistical significance for genomewide studies. Proc. Natl Acad. Sci. USA, 100, 9440-9445.